Incorporating Immune Checkpoint Inhibitors Into Treatment For Patients With HCC

Download this slideset for expert perspectives on current best practices and emerging strategies in immune checkpoint inhibitor therapy for patients with advanced HCC.
Anthony El-Khoueiry, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.21 MB
Released: November 10, 2019

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bayer HealthCare Pharmaceuticals Inc.
Bristol-Myers Squibb
Eisai
Exelixis
Merck & Co., Inc.

Related Content

Gain key insights quickly with this short slideset from Clinical Care Options (CCO) on HER2 testing and targeted therapy in advanced GI cancers

Axel Grothey Headshot Axel Grothey, MD Michael F. Press, MD, PhD Released: September 30, 2020

In this slideset from Clinical Care Options (CCO), experts provide insights on HER2 testing and targeted therapy in advanced gastrointestinal cancers

Axel Grothey Headshot Axel Grothey, MD Michael F. Press, MD, PhD Released: September 25, 2020

From Clinical Care Options, Zofia Piotrowska, MD, MHS, and Stephen V. Liu, MD, review key data from studies of lung cancer treatment presented at ASCO 2020

Stephen V. Liu, MD Zofia Piotrowska, MD, MHS Physicians: maximum of 1.25 AMA PRA Category 1 Credits Released: September 25, 2020 Expired: September 24, 2021

Gain key clinical insights fast, with this short slideset from CCO on lung cancer data presented at 2020 ASCO

Stephen V. Liu, MD Zofia Piotrowska, MD, MHS Released: September 25, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue